Credit Suisse Ag Chemomab Therapeutics Ltd. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
Shares
1 transactions
Others Institutions Holding CMMB
# of Institutions
17Shares Held
2.68MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA2.24MShares$3.56 Million0.05% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$339,2930.08% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il62.4KShares$99,2190.0% of portfolio
-
Kestra Private Wealth Services, LLC31.2KShares$49,6730.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY26.5KShares$42,1810.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $18.2M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...